Login / Signup

The contribution of neuropathology to multiple sclerosis research.

Hans Lassmann
Published in: European journal of neurology (2022)
The results of these studies were highly relevant for the identification of potential therapeutic targets in MS patients and the design of pivotal clinical trials.
Keyphrases
  • multiple sclerosis
  • clinical trial
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • mass spectrometry
  • prognostic factors
  • peritoneal dialysis
  • ms ms
  • white matter
  • phase ii
  • case control